Key statistics
As of last trade CSL Ltd (CSJ:BRN) traded at 180.92, -1.22% below its 52-week high of 183.16, set on Jul 18, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 183.16 |
---|---|
High | 183.16 |
Low | 180.92 |
Bid | 181.16 |
Offer | 185.42 |
Previous close | 180.92 |
Average volume | -- |
---|---|
Shares outstanding | 484.21m |
Free float | 483.71m |
P/E (TTM) | 32.68 |
Market cap | 132.54bn AUD |
EPS (TTM) | 8.37 AUD |
Annual div (ADY) | 2.25 CHF |
---|---|
Annual div yield (ADY) | -- |
Div ex-date | Sep 09 2024 |
Div pay-date | Oct 02 2024 |
Data delayed at least 15 minutes, as of Jul 18 2024.
More ▼
Press releases
- Pharmanovia Acquires Exclusive Rights to Treatment for Parkinson’s Disease
- Self-Amplifying mRNA COVID-19 Vaccine Demonstrates Superior Immune Response Compared with mRNA Vaccine at 12 Months Post-Vaccination
- Japan’s Ministry of Health, Labor and Welfare Approves CSL and Arcturus Therapeutics’ Updated Self-amplifying mRNA COVID-19 Vaccine for Protection against JN.1 Strain, to be Distributed in Japan by Meiji Seika Pharma